Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 21,000 shares at $2.50 ($52,500)
  2. 4 Open-market buy Director bought 10,000 shares at $3.04 ($30,400)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Option exercise Director acquired 16,000 shares (option exercise)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 169,439 shares (to pay taxes)
  10. 4 Open-market buy Director bought 10,000 shares at $3.08 ($30,800)
  11. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.16 ($15,800)
  12. 4 Open-market buy Director bought 5,000 shares at $3.39 ($16,950)
  13. 4 Open-market buy Director bought 10,000 shares at $3.14 ($31,400)
  14. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $3.15 ($15,750)
  15. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $2.85 ($28,500)
  16. 4 Open-market buy Director bought 5,000 shares at $2.82 ($14,100)
  17. 4 Open-market buy Director bought 3,000 shares at an average $2.94 ($8,820)
  18. 4 Open-market buy Director bought 2,000 shares at $3.01 ($6,020)
  19. 4 Open-market buy Director bought 6,000 shares at $2.59 ($15,540)
  20. 4 Open-market buy Director bought 10,000 shares at $2.57 ($25,700)

Page 2 of 24 · 471 filings